SCHEMBL2963859

SCHEMBL2963859

CCOC(=O)CC(C(=O)OCC)N1CC1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.39
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
ALDH1A1 P00352 5/20 0.37
CYP3A4 P08684 2/20 0.37
ALOX15 P16050 2/20 0.37
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
CHRM1 P11229 1/20 0.36
ADORA1 P30542 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TRPA1 O75762 1/20 0.35
KMT2A Q03164 3/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9327548 0.79 MGAM (0.38) CYP2D6MGAMGAASIMGAM2
SCHEMBL9729233 0.77 MAPT (0.53) CYP2D6MGAMGAASIMGAM2
SCHEMBL23376910 0.72 MAPT (0.64) CYP2D6MGAMGAASIMGAM2
SCHEMBL28794446 0.72 MAPT (0.64) CYP2D6MGAMGAASIMGAM2
SCHEMBL7306746 0.70 MAPT (0.47) CYP2D6MGAMGAASIMGAM2
SCHEMBL7306734 0.70 MAPT (0.47) CYP2D6MGAMGAASIMGAM2
SCHEMBL23130583 0.69 ALDH1A1 (0.35) GAAALDH1A1TSHRHSD17B10L3MBTL1
SCHEMBL13868417 0.68 MGAM (0.44) MGAMGAASIMGAM2ALDH1A1
SCHEMBL740740 0.67 MGAM (0.48) CYP2D6MGAMGAASIMGAM2
SCHEMBL29926915 0.67 MGAM (0.48) CYP2D6MGAMGAASIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759452-B2 Aspartic ester functional compounds BAYER MATERIALSCIENCE LLC (US) 2010-07-20 US disclosed
US-20090142601-A1 ASPARTIC ESTER FUNCTIONAL COMPOUNDS COVESTRO LLC 2009-06-04 US disclosed
EP-1627868-B1 Aspartic ester functional compounds BAYER MATERIALSCIENCE LLC (US) 2007-12-19 EP disclosed
EP-1627868-A2 Aspartic ester functional compounds Bayer MaterialScience LLC (US) 2006-02-22 EP disclosed
US-20060011295-A1 Aspartic ester functional compounds BAYER MATERIAL SCIENCE LLC 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060011295-A1 Aspartic ester functional compounds DDO, CDH1, ICAM1 CYP2D6 4115/4885MGAM 3758/4885GAA 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.